Aims & Scope
Pharmaceutical Nanotechnology publishes original manuscripts, reviews, thematic issues, rapid technical notes and commentaries that provide insights into the synthesis, characterisation and pharmaceutical (or diagnostic) application of materials at the nanoscale. The nanoscale is defined as a size range of below 1 µm. Scientific findings related to micro and macro systems with functionality residing within features defined at the nanoscale are also within the scope of the journal. Manuscripts detailing the synthesis, exhaustive characterisation, biological evaluation, clinical testing and/ or toxicological assessment of nanomaterials are of particular interest to the journal’s readership. Articles should be self contained, centred around a well founded hypothesis and should aim to showcase the pharmaceutical/ diagnostic implications of the nanotechnology approach. Manuscripts should aim, wherever possible, to demonstrate the in vivo impact of any nanotechnological intervention. As reducing a material to the nanoscale is capable of fundamentally altering the material’s properties, the journal’s readership is particularly interested in new characterisation techniques and the advanced properties that originate from this size reduction. Both bottom up and top down approaches to the realisation of nanomaterials lie within the scope of the journal.
Cabells Journalytics, Biological Abstracts, BIOSIS Previews, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, Google Scholar, J-Gate, JournalTOCs, MEDLINE/PubMed, Open Abstracts (I4OA), QOAM, Scilit, Scopus, Suweco CZ and Ulrich's Periodicals Directory
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
I appreciate your support on these process. It was an honour to publish in your prestigious journal.
Those are the words: " Publish with Bentham Sciences is join the researchers in a big network science friendship relationship around the world".
Thanks a lot
Dr. Patricia Durán Ospina
(Fundación Universitaria del Área Andina Colombia, Pereira,United States)